Sign Up to like & get
recommendations!
0
Published in 2018 at "American journal of human genetics"
DOI: 10.1016/j.ajhg.2018.01.005
Abstract: 15q13.3 microdeletion syndrome is characterized by a wide spectrum of neurodevelopmental disorders, including developmental delay, intellectual disability, epilepsy, language impairment, abnormal behaviors, neuropsychiatric disorders, and hypotonia. This syndrome is caused by a deletion on chromosome…
read more here.
Keywords:
15q13 microdeletion;
microdeletion syndrome;
mice;
syndrome ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2019 at "Cytokine"
DOI: 10.1016/j.cyto.2019.154879
Abstract: Carriers of the human 15q13.3 microdeletion (MD) present with a variable spectrum of neuropathological phenotypes that range from asymptomatic to severe clinical outcomes, suggesting an interplay of genetic and non-genetic factors. The most common 2 MB…
read more here.
Keywords:
immune;
15q13 microdeletion;
low dose;
immune responses ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "European Neuropsychopharmacology"
DOI: 10.1016/j.euroneuro.2017.08.132
Abstract: Background The 15q13.3 microdeletion syndrome is caused by a 1.5 MB hemizygous microdeletion at chromosome 15q13.3 affecting seven genes: FAN1, MTMR10, TRPM1, MIR211, KLF13, OTUD7A, and CHRNA7. The 15q13.3 microdeletion increases the risk of intellectual…
read more here.
Keywords:
15q13 microdeletion;
mouse models;
microdeletion syndrome;
microdeletion ... See more keywords